Substantial improvement in a Meige's syndrome patient with levetiracetam treatment

Theresa A. Zesiewicz, Elan D. Louis, Kelly L. Sullivan, Martin Menkin, Peter B. Dunne, Robert A. Hauser

Research output: Contribution to journalArticle

19 Scopus citations

Abstract

We report on a woman with idiopathic Meige's syndrome whose dystonia improved with the use of levetiracetam (LEV, Keppra, UCB Pharma, Smyrna, GA). This report and data from an animal model of paroxysmal dystonia suggest that LEV might be helpful in the treatment of dystonia.

Original languageEnglish (US)
Pages (from-to)1518-1521
Number of pages4
JournalMovement Disorders
Volume19
Issue number12
DOIs
StatePublished - Dec 1 2004
Externally publishedYes

Keywords

  • Cervical dystonia
  • Keppra
  • Levetiracetam
  • Meige's syndrome

ASJC Scopus subject areas

  • Neurology
  • Clinical Neurology

Fingerprint Dive into the research topics of 'Substantial improvement in a Meige's syndrome patient with levetiracetam treatment'. Together they form a unique fingerprint.

  • Cite this

    Zesiewicz, T. A., Louis, E. D., Sullivan, K. L., Menkin, M., Dunne, P. B., & Hauser, R. A. (2004). Substantial improvement in a Meige's syndrome patient with levetiracetam treatment. Movement Disorders, 19(12), 1518-1521. https://doi.org/10.1002/mds.20233